What amount sold does Phoam Labs, Inc. report in Form D filings?

The latest linked filings report $2.5M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Phoam Labs, Inc.'s most recent SEC filing?

Phoam Labs, Inc.'s most recent Form D filing was on 2026-04-24.

How many investors does Phoam Labs, Inc. have?

The most recent Form D filing lists 13 investor(s).

What type of securities does Phoam Labs, Inc. offer?

Phoam Labs, Inc.'s SEC Form D filings indicate equity offerings.

Phoam Labs, Inc.

CIK: 0001912757·Manufacturing·EDEN PRAIRIE, MN·Corporation·Founded 2022

Reported Sold

$2,484,008

Total Filings

Identified Offerings

Last Filed

Apr 24, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Manufacturing industry

SEC EDGAR

Offering filing timeline

Apr 24, 2026Form D — New notice

Reported sold: $1,164,008 · Target: $4,000,126

Rule 506(b)·13 investors

Sep 19, 2024Form D — New notice

Reported sold: $820,000 · Target: $2,250,000

Rule 506(b)·4 investors

Feb 28, 2022Form D — New notice

Reported sold: $500,000 · Target: $500,000

Rule 506(b)·13 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 3 identified offerings

$2,484,008

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

John C Parnell

Related Person

Appears on 1 filing

Elizabeth Dundee Butcher

Related Person

Appears on 1 filing

Ian Butcher

Related Person

Appears on 1 filing

John C Parnell

Related Person

Appears on 1 filing

Elizabeth Dundee Butcher

Related Person

Appears on 1 filing

Ian Butcher

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 24, 2026	New	$4,000,126	$1,164,008	13
Sep 19, 2024	New	$2,250,000	$820,000	4
Feb 28, 2022	New	$500,000	$500,000	13

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

RxFunction, Inc.

Manufacturing

Offering target: $4,290,592

Filed Oct 14, 2026